Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
IL3RA identified as novel biomarker and therapeutic target for ER breast cancer through plasma proteome-wide mendelian randomization and TCGA database analysis
Saved in:
| Published in: | Clinical Proteomics |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: IL3RA identified as novel biomarker and therapeutic target for ER breast cancer through plasma proteome-wide mendelian randomization and TCGA database analysis
- Systematic Druggable Genome‐Wide Analysis Identifies Therapeutic Targets for Aging: A Mendelian Randomization Study
- Machine learning and network pharmacology identify keloid biomarkers (AMPH, TNFRSF9) and therapeutic targets (IL6, HAS2) for aloe-derived quercetin
- Impact of preanalytical factors on plasma extracellular vesicles and human plasma proteome
- Plasma proteomics identifies proteins and pathways associated with incident migraine in 50,668 adults
- Ivermectin inhibits ER, HER2, and TGF-β pathways in ER-positive and endocrine-resistant breast cancer cells
- Systematic prioritization of potential therapeutic targets for glomerulonephritis using multi-omics Mendelian randomization